Tomas Grippo, MD, Stela Vujosevic, MD, and Raffaele Turano, MD
Show Description +
Dr. Tomas Grippo (Argentina), Dr. Stela Vujosevic (Italy), and Dr. Raffaele Turano (Italy) share the versatility of our laser systems that expand ways to manage, preserve and prolong vision at the European Society of Cataract and Refractive Surgeons (ESCRS) congress in Milan, Italy.
Posted: 8/29/2023
Tomas Grippo, MD, Stela Vujosevic, MD, and Raffaele Turano, MD
Dr. Tomas Grippo (Argentina), Dr. Stela Vujosevic (Italy), and Dr. Raffaele Turano (Italy) share the versatility of our laser systems that expand ways to manage, preserve and prolong vision at the European Society of Cataract and Refractive Surgeons (ESCRS) congress in Milan, Italy.
Posted: 8/29/2023
Treat and Extend with PASCAL Laser
DIAMONDS: A Randomized Controlled Trial Designed with Patients in Mind
The Clinical and Economic Argument for MicroPulse® Laser in a Retinal Practice
Comprehensive Ophthalmologists Discuss Practice Benefits of Transscleral Laser Therapy (TLT) with MicroPulse® Technology for a Broad Range of Glaucoma Patients
MicroPulse® Transscleral Laser Therapy for the Treatment of Glaucoma: Guidelines from an International Delphi Panel
About Iridex
Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems for the ophthalmology market. The Company’s proprietary MicroPulse technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma, diabetic macular edema (DME), and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors.
Follow Iridex